Die Häufigkeit der Nebenwirkungen bei der Mutter und ihrem Säugling war in der Silgard-Gruppe und in der Placebogruppe vergleichbar.
In breastfeeding mothers given Silgard or placebo during the vaccination period of the clinical trials the rates of adverse reactions in the mother and the breastfed infant were comparable between the vaccination and the placebo groups.